Showing posts with label sorafenib. Show all posts
Showing posts with label sorafenib. Show all posts
Tuesday, April 7, 2020

Tivozanib Bests Sorafenib in Metastatic Renal Cell Carcinoma

›
In continuation of my update on  Tivozanib   and  Sorafenib Among patients with metastatic renal cell carcinoma, progression-free ...
Monday, September 18, 2017

Sorafenib effect on HCC survival depends on hepatitis status

›
For patients with advanced unresectable hepatocellular carcinoma, the effect of sorafenib on overall survival (OS) is dependent on patient...
Thursday, February 16, 2017

Novel combination therapy shows strong response in phase 1 trial

›
In continuation of my update on Sorafenib , Premetrexed ,   Vandetanib "Though phase 1 studies are designed to evaluate the safety ...
Tuesday, May 12, 2015

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

›
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvan...
Thursday, November 15, 2012

Scientists show how sorafenib can be dangerous to the heart..

›
In continuation of my update on  sorafenib Studying mice with the equivalent of a heart attack, researchers found that the drug sor...
Tuesday, June 22, 2010

Synergistic activity of Sorafenib and Sulforaphane abolishes pancreatic cancer...

›
In continuation of my update on " Sorafenib ", I find this info interesting to share with... A team led by Professor Dr. Ingrid H...
2 comments: